Public Comments to Agencies | Page 3 | Citizens Against Government Waste

Public Comments to Agencies

Agency Comments

CAGW Files Comments Regarding Use of Distributed Transmission System Technologies

On December 11, 2020, CAGW filed comments with the FCC urging the agency to hold off voting on a proposal that would allow for increased signals for Next Generation TV that could disrupt the use of TV white space technology for rural broadband...

Cody Leach December 11, 2020
Agency Comments

CAGW Asks President to Halt the Most Favored Nation Policy

Using the MFN policy for pharmaceuticals is simply more price controls that will further distort the market and harm biopharmaceutical research.  

Frances Floresca November 16, 2020
Agency Comments

CAGW Files Letter regarding Use of 12 GHz Spectrum Band

CAGW strongly urges the FCC to deny the April 26, 2016 petition request of the MVDDS 5G Coalition.

Deborah Collier October 22, 2020
Agency Comments

CAGW Comments to the NAIC Concerning Pharmacy Benefit Managers

CAGW writes comments to the National Association of Insurance Commissioners regarding draft model legislation concerning pharmacy benefit managers.

Elizabeth Wright September 11, 2020
Agency Comments

CAGW Comments to FCC on Declaratory Petition on Pole Attachments

Deploying broadband to unserved areas of the country has long been a top priority for the FCC.

Deborah Collier September 2, 2020
Agency Comments

CAGW Tells HHS to Reject State AGs Request to Steal Gilead’s Patent

CAGW urges the U.S. Department of Health & Human Services to not steal Gilead's patent, which was requested by state attorney generals. 

Frances Floresca August 7, 2020
Agency Comments

Coalition Urges FCC to Grant the Petition of Charter Communications

A coalition of organizations filed comments with the FCC regarding data caps and usage pricing.

Thomas Schatz July 24, 2020
Agency Comments

CAGW Supports a Consistent Cost-Benefit Analysis for the Clean Air Act

The EPA must ensure that the Clean Air Act rules proposed under the Advance Notice of Proposed Rulemaking must provide consistent and high quality cost-benefit analyses for significant rules.

CAGW Staff July 22, 2020
Agency Comments

Coalition Urges CMS to Oppose a Significant Regulatory Expansion of the Medicaid Drug Rebate Program

Coalitions urges CMS Admin to oppose regulatory expansion of the Medicaid Drug Rebate Program. 

Frances Floresca July 21, 2020
Agency Comments

CAGW urges White House to Withdraw Proposed EOs regarding Foreign Reference Drug Pricing

CAGW asks the White House Chief of Staff to withdraw any proposed Executive Orders regarding foreign drug pricing. 

Frances Floresca July 20, 2020
Agency Comments

CAGW Comments to the FERC on Net Metering

CAGW files comments in favor of New England Ratepayers Association's petition concerning wholesale energy sales. 

Frances Floresca June 15, 2020
Agency Comments

CAGW Comments to Philippine FDA on Vapor Product Regulation

CAGW expresses its disappointment over the Philippine Food and Drug Administration’s draft guidelines, “Regulation of Vapor Products and Heated Tobacco Products.”

Peter Klensch June 2, 2020

Pages